322 W 57TH ST. #33B, NEW YORK, NY
Separation Agreement with Steven Nelson; Departure as President and CCO
Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Steven Nelson's Medical Leave Extended Indefinitely
Changes in Board, Management or Compensation, Other Events
DarioHealth Corp Enters $20 Million Sales Agreement with A.G.P.
DarioHealth Corp. Amends Bylaws; Stockholder Approval Received
2026 Annual Meeting Results; Directors Elected at DarioHealth Corp.
Annual Report to Security Holders
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Specialized Disclosure Report
Submission Upload
Correspondence